12.02.2026

Part THREE: insights into our projects

#

🌍 Part THREE: insights into our projects 🌍

From challenging local market accesses into a global approval strategy – powered by our network

 

🔍 Take a look at the third published market access project, which turned into a global task.

💰 A manufacturer with a well-established active substance and approval limited to Germany initially asked for our support to figure out attractive pricing potentials in European countries, and later in the project also in Australia and New Zealand.

 

💪 The challenge:

Across Europe and beyond, market access processes vary widely in scope, complexity, and timelines. The challenge wasn’t only to collect country-specific insights, but also to connect and consolidate them in a way that enabled clear strategic decision-making.

 

The key questions:

1️⃣ What pricing potential can be achieved in individual markets?

2️⃣ How is national market access structured, and which requirements must be met?

 

🌐 How did our Accessus Health network make it possible?

🔹 With local expertise in each country,

🔹 country-specific insights, tailored to the client’s decision needs,

🔹 centralized project management: coordination and consolidation of all inputs,
🔹 and with a network beyond Europe, with experts in Australia and New Zealand.

 

🎯 The outcome:

✅ With one single point of contact to multiple markets insights,
✅ comparable information across 14 countries,  
✅ transparency on pricing potential and market access effort,

✅ a clear short summary of extensive detailed information that allows to quickly defining a strategy,
✅ flexibility to expand the scope to additional countries at any time.